Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer's disease by network pharmacology and molecular docking

S Cheung, Y Zhong, L Wu, X Jia, MQ He, Y Ai… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Guhan Yangshengjing (GHYSJ) is an effective
prescription for delaying progression of Alzheimer's disease (AD) based on the ancient …

[HTML][HTML] A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's …

Q Zeng, L Li, W Siu, Y Jin, M Cao, W Li, J Chen… - Biomedicine & …, 2019 - Elsevier
Abstract Chaihu Shugan San (CSS) is a well-known herbal formula used to nourish liver and
blood, promote blood circulation and Qi flow in Traditional Chinese Medicine. Modern …

Network Pharmacology and Molecular Docking‐Based Strategy to Investigate the Multitarget Mechanisms of Shenqi Yizhi Granule on Alzheimer's Disease

L Wang, X Xu, Z Wang, Q Chen, X Wei… - Evidence‐Based …, 2022 - Wiley Online Library
Background. Traditional Chinese herbal medicine draws more attention to explore an
effective therapeutic strategy for Alzheimer's disease (AD). Shenqi Yizhi granule (SQYG), a …

Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease

J Zhi, L Yin, Z Zhang, Y Lv, F Wu, Y Yang… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Jin-Si-Wei (JSW), a traditional Chinese medicine
(TCM) formula, have cognitive enhancing effect and delay the memory decline in an animal …

Network Pharmacology‐Based Study of the Underlying Mechanisms of Huangqi Sijunzi Decoction for Alzheimer's Disease

W Zhang, M Lv, Y Shi, Y Mu, Z Yao… - … and Alternative Medicine, 2021 - Wiley Online Library
Background. Huangqi Sijunzi decoction (HQSJZD) is a commonly used conventional
Chinese herbal medicine prescription for invigorating Qi, tonifying Yang, and removing …

[HTML][HTML] Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer's disease

W Xu, B Ren, Z Zhang, C Chen, T Xu, S Liu… - Frontiers in …, 2022 - frontiersin.org
There is yet no effective drug for Alzheimer's disease (AD) which is one of the world's most
common neurodegenerative diseases. The Qin-Zhi-Zhu-Dan Formula (QZZD) is derived …

Elucidating the therapeutic mechanism of Hengqing II decoction in Alzheimer's disease using network pharmacology and molecular docking techniques

Y Wang, J Jiang, S Chen, Q Chen, X Yan, X Shen - Fitoterapia, 2024 - Elsevier
Purpose The aim of our research was to investigate the mechanism of the Hengqing II
decoction in treating Alzheimer's disease (AD) through network pharmacology and …

Active compounds and targets of yuanzhi powder in treating alzheimer's disease and its relationship with immune infiltration based on HPLC fingerprint and network …

Q Liu, S Wang, Y Hao, J Li, W Li… - Evidence‐Based …, 2022 - Wiley Online Library
Background. Yuanzhi powder (YZP) has been extensively investigated as a natural
prescription with therapeutic benefits for Alzheimer's disease (AD). However, its active …

[HTML][HTML] Molecular Biological Mechanisms of Yuan Zhi Powder in the Treatment of Alzheimer's Disease: an Analysis Based on Network Pharmacology

WJ Qiang, Y Chen, FY He, MF Xiao, WY Cai… - Digital Chinese …, 2018 - Elsevier
Objective To predict the main active ingredients, potential targets and molecular
mechanisms of Yuan Zhi powder in treatment of dementia by using network pharmacology …

Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer's disease based on network pharmacology and molecular docking …

F Lv, M Sun, C Qin, D Du, X Zheng, W Li - Pharmaceutical Biology, 2024 - Taylor & Francis
Abstract Context In China, HUANGQI is widely used for the treatment of Alzheimer's disease
(AD). However, a comprehensive understanding of its mechanism of anti-AD effects is …